Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safety of newly approved drugs: implications for prescribing.

Literature DB >> 11980528

Safety of newly approved drugs: implications for prescribing.

Robert J Temple, Martin H Himmel.

Abstract

Mesh：

Year: 2002 PMID： 11980528 DOI： 10.1001/jama.287.17.2273

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

35 in total

Review 1. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors: Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal: Toxicol Sci Date: 2010-06-10 Impact factor: 4.849

Review 2. Utility of nutraceutical products marketed for cognitive and memory enhancement.

Authors: Graham J McDougall; Vonnette Austin-Wells; Teena Zimmerman
Journal: J Holist Nurs Date: 2005-12

3. Sources of information used by regulatory agencies on the generation of drug safety alerts.

Authors: Carlos Alves; Ana Filipa Macedo; Francisco Batel Marques
Journal: Eur J Clin Pharmacol Date: 2013-07-27 Impact factor: 2.953

4. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).

Authors: K Pachkoria; M I Lucena; F Ruiz-Cabello; E Crespo; M R Cabello; R J Andrade
Journal: Br J Pharmacol Date: 2007-02-05 Impact factor: 8.739

5. Involvement of natural killer T cells in halothane-induced liver injury in mice.

Authors: Linling Cheng; Qiang You; Hao Yin; Michael P Holt; Cynthia Ju
Journal: Biochem Pharmacol Date: 2010-03-30 Impact factor: 5.858

6. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.

Authors: Allen D Brinker; Jenna Lyndly; Joseph Tonning; David Moeny; Jonathan G Levine; Mark I Avigan
Journal: Drug Saf Date: 2013-12 Impact factor: 5.606

Safety of newly approved drugs: implications for prescribing.

Review 1. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Review 2. Utility of nutraceutical products marketed for cognitive and memory enhancement.

3. Sources of information used by regulatory agencies on the generation of drug safety alerts.

4. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).

5. Involvement of natural killer T cells in halothane-induced liver injury in mice.

6. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.

7. Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.

Review 8. Mechanisms of drug-induced liver injury.

Review 9. Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Review 10. Current concepts of mechanisms in drug-induced hepatotoxicity.